A significant shift in Canadian drug policy has happened, as the regulators announce the use of psilocybin mushrooms for therapeutic purposes. Until now, these substances were strictly restricted, but a growing body of research suggests they could offer relief for psychological issues like PTSD. This change represents a major step toward reconsider